New Discussion Groups for Big, Small, Mid-Sized Pharma & Generics

Ensuring your Gross-to-Net calculations are accurate is a messy business, and now more than ever, enormous complexity exists due to a shifting payer mix stemming from healthcare reform.

At IIR’s 2nd Annual Gross-to-Net Accounting Forum, we know how important it is for you to be able to benchmark your systems and methodologies against best practices—and that the calculations are very different for large, small to mid-sized pharma, and generic companies. For that reason, we are introducing new unique tailored discussion groups specific to your company size and function where you can discuss and share challenges with like-minded peers.

Collaborate across managed markets, commercial, government programs and finance with your dedicated discussion group leaders:

• Big Pharma – Courtney Callihan, Finance Director, GlaxoSmithKline
• Small to Mid-Sized Pharma – Larry Breen, Director of Financial Planning and Analysis, Sunovion Pharmaceuticals
• Generics – Roxana Santiago, Senior Finance Manager Gross to Net, Hospira Worldwide, Inc. 

To full our full program, download the 2014 brochure.

Register today using code XP1911BLOG and receive 15% off the standard rate. If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage. We look forward to seeing you June 17-18 in Philadelphia!

Best,
The GTN Team

Opt-in for updates
Follow us on Twitter
GTN LinkedIn